I just want to ask one more question.
Within the Canadian Armed Forces, mefloquine accounts for less than 5% of malarial prevention prescriptions now. Since June 2017, mefloquine has been recommended only when members requested it themselves. I believe this, to a large extent, is due to the work that we've been able to do to date in Canada to draw better awareness to the impacts of this drug.
It's only used when they request it or when other drugs aren't able to be used. That sounds very good to me, but there's a huge gap in dealing with those who have suffered in the past when they were required to take this drug within Canada.
Dr. Douglas, what would you say to this? This is a new directive for future use but what about other measures in regard to Canadian Armed Forces members and veterans who were required to take it, who are facing injuries, and nothing has been done significantly by anyone to draw their attention to this?